Gabapentin for Pruritus in Palliative care

@article{Anand2013GabapentinFP,
  title={Gabapentin for Pruritus in Palliative care},
  author={Sheeba Anand},
  journal={American Journal of Hospice and Palliative Medicine{\textregistered}},
  year={2013},
  volume={30},
  pages={192 - 196}
}
  • Sheeba Anand
  • Published 2013
  • Medicine
  • American Journal of Hospice and Palliative Medicine®
Itch/pruritus can be very distressing in palliative care population and often is difficult to treat. Conventional antihistamines lack efficacy. Cutaneous and central pathogenesis of itch is extremely complex and unclear, making its treatment challenging. Neuronal mechanisms have been identified in the pathophysiology of itch hence providing a myriad of therapeutic options. It has been established that pruritus and pain neuronal pathway interact with each other, hence neuropathic analgesics like… Expand
Review of management of pruritus in palliative care
TLDR
Since severe pruritus seen in patients with advanced disease can be associated with failure of different organ systems,Pruritus must be assessed based on the underlying organ systems and the pathophysiology involved and specific approach and medications must be considered. Expand
Pharmacological interventions for pruritus in adult palliative care patients.
TLDR
This is an update of the original Cochrane review published in 2013 and includes 39 different treatments for pruritus in four different patient groups, mainly due to imprecision and risk of bias. Expand
Evaluation of Therapies for Peripheral and Neuraxial Opioid-induced Pruritus based on Molecular and Cellular Discoveries
TLDR
The mechanisms and effectiveness of existing medications used for clinical management of pruritus will be evaluated, and the emerging preclinical utility of selective κ-opioid receptor agonists, such as nalfurafine, for the management of opioid-inducedPruritus is highlighted. Expand
Use of antiepileptic mood stabilizers in dermatology.
TLDR
Gabapentin (dosage range 300-3600 mg daily) is the most widely studied AED mood stabilizer in dermatology and is especially effective in situations where CNS sensitization is a mediating factor. Expand
Pruritus ani: diagnosis and treatment.
TLDR
The pathophysiology of itching, an overview of primary and secondary causes, and various treatment options are reviewed. Expand
Scalp Pruritus: Review of the Pathogenesis, Diagnosis, and Management
TLDR
This review article focuses on the understanding of the pathophysiology and the diagnostic and therapeutic management of scalp pruritus. Expand
Pruritus: Is there a grain of salty truth?
TLDR
Both the tissue sodium loading and pruritus responded fully to initiation of expanded hemodialysis therapy with a recently introduced medium cutoff dialysis membrane‐based dialyzer, measured with Sodium‐23 magnetic resonance imaging. Expand
Treatment of Brachioradial Pruritus: A Systematic Review
TLDR
Low-quality evidence supports the use of sun protection, topical capsaicin, or oral gabapentin as effective therapeutic modalities for BRP, and clinicians should be aware of possible underlying cervical spine pathology. Expand
Pruritus in patients with solid tumors: an overlooked supportive care need
TLDR
Pruritus is an under-addressed symptom in patients with solid tumors and an intervention was recommended/prescribed in only 7% of visits, suggesting additional research is needed to understand the burden of pruritus in affected populations. Expand
Understanding itch in systemic sclerosis in order to improve patient quality of life.
TLDR
The putative mechanisms of the pathogenesis of itch are discussed to better understand the mechanisms that may be relevant to pruritus in SSc and possible therapeutics in the context of this complex pathogenesis. Expand
...
1
2
3
...

References

SHOWING 1-10 OF 45 REFERENCES
Paroxetine for pruritus in advanced cancer.
TLDR
It is suggested that paroxetine's antipruritic effect may be explained by rapid downregulation of the 5-HTs receptors, which may have an important role in the generation of pruritus and pain. Expand
Efficacy of gabapentin in the management of pruritus of unknown origin.
TLDR
Generalized pruritus is a distressing symptom that can occur in several dermatologic and systemic disorders and most commonly occurs in older patients and persists for long periods, from months to years. Expand
Topical therapies for pruritus.
TLDR
Current topical therapies to treat pruritus are summarized, potential future therapies are discussed, and potential treatments for itch are discussed. Expand
Neurophysiological and neurochemical basis of modern pruritus treatment
TLDR
Recent developments show that highlighting the basis of pruritus offers modern neurophysiological and neurochemical therapeutic models and the possibility to treat patients with refractory itching of different origin. Expand
Brachioradial pruritus successfully treated with gabapentin
TLDR
A 64‐year‐old man with BRP who showed good response to gabapentin therapy is reported, who is likely to have had previous treatment with non‐steroidal anti‐inflammatory drugs and topical capsaicin. Expand
Pruritus in Burns: Review Article
TLDR
The area of burns pruritus is under-researched and large-scale studies are required to reinforce the armamentarium of specialists with evidence-based regimens for the treatment of this highly distressing symptom. Expand
Pruritus in cancer patients.
TLDR
The pathogenesis, causes, effects and treatment options for pruritus in cancer patients are discussed, and some high quality studies exist. Expand
Pruritus: management algorithms and experimental therapies.
TLDR
This work presents possible therapeutic ladders that form the basis for effective therapeutic itch strategies in various diseases and summarizes current exciting developments of experimental strategies in itch research and in clinical development for itch therapy. Expand
The role of gabapentin in treating diseases with cutaneous manifestations and pain
TLDR
Gabapentin appears to be a promising agent in the treatment of pain, alterations of sensation and pruritus associated with dermatological disease, but no review of these uses exists. Expand
Novel Management of Pruritus in Patients Treated With IL-2 for Metastatic Renal Cell Carcinoma and Malignant Melanoma
TLDR
It is suggested that gabapentin should be considered an effective and safe treatment in IL-2-relatedPruritus, and this concept could be applied to pruritus encountered in similar clinical settings. Expand
...
1
2
3
4
5
...